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Resumo: 
O tratamento de primeira linha do Síndrome de Overlap (SO) é a ventilação noturna com sistemas 
com pressão positiva com/sem oxigenoterapia. A adesão ao tratamento é inquietante e, tanto 
quanto sabemos, há poucos estudos de preditores da adesão ao tratamento nesta população. 
O objetivo deste estudo é analisar, retrospetivamente, os preditores da adesão ao tratamento 
com sistemas de ventilação com pressão positiva em doentes com SO. 
Selecionámos 50 doentes (49 a fazer BiPAP e 1 CPAP) da consulta de Doenças Respiratórias do Sono 
sob tratamento desde Janeiro de 2003. Posteriormente obtivemos dados das titulações da ventilação 
e da adesão ao tratamento através dos cartões eletrónicos dos ventiladores. 
A média de idades era de 69 anos, 76% indivíduos do género masculino, 44% sob oxigenoterapia. A 
média de tempo de uso do sistema de ventilação foi de 38 meses, variando de 4-104 meses. A média 
de uso foi de 6:53horas/noite, 74% usaram o ventilador>70% das noites. Encontrámos uma 
correlação positiva da PaCO2 pré-titulação (p<0.031) e PaO2 pós-titulação (p<0.037) com a adesão 
ao tratamento. Não encontrámos correlação da gravidade subjetiva da doença e do Índice de 
Apneia-Hipopneia com a adesão. Quando analisámos as exacerbações de Doença Pulmonar 
Obstrutiva Crónica, não pudemos verificar qualquer benefício do tratamento. 
Desta análise, os doentes tinham melhor adesão que em estudos anteriores, provavelmente 
 
 
porque a nossa amostra tinha uma média de idade mais alta e doença mais grave. A PaCO2 pré-
titulação e a PaO2 pós-titulação foram os únicos preditores de adesão ao tratamento que 
encontrámos, de entre as variáveis analisadas. 
Serão necessários estudos subsequentes com amostras maiores nesta área para novas conclusões. 
 
Palavras-chave: Síndrome de Overlap, Doença Pulmonar Obstrutiva Crónica, Síndrome de Apneia 
Obstrutiva do Sono, Ventilação Não-Invasiva com Pressão Positiva, CPAP, BiPAP, Adesão. 
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Abstract 
Overlap Syndrome (OS) first line treatment is nocturnal ventilation with positive pressure 
systems with/without oxygen supplementation. However, the adherence to treatment is a 
concern and, to our knowledge, there are few studies of predictors to adherence in this 
population.  
The objective of this study is to evaluate retrospectively the predictors of adherence to 
treatment with positive pressure systems in OS patients.  
We selected 50 patients (49 treated with BiPAP and 1 with CPAP) from our Sleep Disordered 
Breathing outpatient clinic under treatment since January 2003. After that, we collected 
clinical data from ventilation titration records and adherence data from ventilators’ electronic 
cards.  
The average age in our sample was 69 years, 76% were males, 44% were on oxygenotherapy. 
The mean use time of positive pressure ventilation systems was 38 months, ranging from 4 up 
to 104 months. The mean usage time was 6:53hours/night, 74% used the ventilator>70% of 
the nights. We found a positive correlation of pre-titration PaCO2 (p<0.031) and post-titration 
PaO2 (p<0.037). We did not observe any correlation of subjective disease severity and 
Apnea-Hypopnea Index to adherence. When we analyzed the pre and post treatment Chronic 
Obstructive Pulmonary Disease exacerbations we could not attain any benefit from it.  
From our analysis, patients had better adherence than previous series, probably because our 
sample was older and had superior disease severity. Pre-titration PaCO2 and post-titration 
PaO2 were the only predictors of adherence to treatment among the analyzed variables. 
Further studies with increased sampling are required to provide further conclusions in this 
subject. 
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Introduction 
In 1985, David Flenley called the co-existence of Chronic Obstructive Pulmonary Disease 
(COPD) and Obstructive Sleep Apnea Syndrome (OSAS) the Overlap Syndrome (OS)(1). 
Both diseases are common: COPD affects 10% and OSAS 5% of the adult population over 40 
years of age, so their coexistence is expected to occur in about 0.5% of this population(2).  
In OS there is an increased risk of morbidity and mortality than in isolated COPD or 
OSAS(3).  Patients with OS have a higher risk of hypercapnia (4), more frequent and 
pronounced oxygen desaturation and more total sleep time with hypoxemia and 
hypercapnia(5,6). This can lead to daytime pulmonary hypertension and right heart 
failure(5,7,8). Daytime hypercapnia correlates with more severe sleep-disordered breathing 
and worse nocturnal hypoxemia(6). 
Continuous positive airway pressure is the first line treatment in OSAS, but may be inefficient 
and nighttime hypoxemia may persist in patients with associated COPD. So it may be 
necessary to add oxygen or even shift to  Bi-level Positive Airway Pressure, also known as 
nocturnal noninvasive positive pressure ventilation(2). Treatment reduces COPD 
exacerbations, hospitalizations rate and improves survival(5).  
Adherence to treatment with positive pressure systems is crucial for a good clinical outcome, 
symptoms’ improvement, better quality of life, reduction of cardiovascular disease risk and 
morbidity and mortality rates(9,10). It is known that adherence pattern is established early, in 
the first week of treatment, and predicts long term use(9).  
Nowadays, measuring the compliance with positive pressure system devices is objective(10), 
unlike most pharmaceutical interventions. The nightly duration of therapy at effective 
pressure is recorded in smart cards, modem or web-based methodology(9). 
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To our knowledge, few reports on the predictors of adherence to positive pressure systems’ 
treatment in OS patients have been published. Therefore our study’s goal is to evaluate 
retrospectively the predictors of adherence to treatment with positive pressure systems in OS 
patients. 
 
  
6 
 
Methods 
Study design 
An observational retrospective study was performed.  The protocol was approved by the São 
João Hospital Ethics Committee and the study was performed in accordance with the 
guidelines of the Declaration of Helsinki and its current revision. 
Subjects 
Fifty patients diagnosed with OS and under treatment for at least 6 months were included in 
this study. All patients were enrolled in treatment with a positive pressure system from 
January 2003 until February 2011.  
These individuals presented a history of chronic bronchitis or emphysema with irreversible or 
partially reversible airway obstruction, FEV1/FVC < 0.70(11) and hypersomnolence with an 
Apnea-Hypopnea Index (AHI) > 5 in a polysomnographic study(8).  
Patients were adapted to ventilation in a short 2 hours session through increments in the level 
of inspiratory pressure (IPAP), aiming at the higher levels that achieved the best oxygen 
saturation levels, transcutaneous CO2 and patient tolerance. At least 4cmH2O of expiratory 
pressure (EPAP) was added to counteract the intrinsic positive end-expiratory pressure. EPAP 
was further increased according to AHI and thoracic and abdominal excursions to control 
respiratory events. Oxygen was added to maintain SpO2>90% during the run-in period of 
adaptation. Eleven individuals had a split-night polysomnography at diagnosis with a Sleep 
Technician monitoring the sleep study in our laboratory, while the remaining individuals had 
domiciliary oxymetry, domiciliary polysomnography or cardiorespiratory polygraphy. Re-
titration was performed during a split-night polissonography. Five different models of 
ventilators were used:  VPAP III ST-A, ResMed® (n=9) VPAP IV ST, ResMed® (n =7), 
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BiPAP Harmony, Philips Respironics® (n=21), BiPAP Pro, Philips Respironics® (n=6), Vivo 
30, Breas® (n=3), Vivo 40, Breas® (n=2), iSleep20, Breas® (n=1), 1 missing. 
All individuals with respiratory co-morbidities (hypoventilation-obesity syndrome, Cheyne-
Stokes breathing, α1-antitrypsin deficiency) were excluded.  
Data collection strategy 
Our data was collected from documents obtained in each titration report, clinical process and 
respiratory functional tests.  
Records on COPD exacerbations episodes (defined as episodes of worsening in baseline 
dyspnea, cough and/or sputum(11)) that lead patients to look for medical care at the 
emergency service and hospitalizations were collected from each patient clinical process. We 
included episodes since January 2007, at São João Hospital, Oporto, with a total number of 23 
patients out of 50. 
Data concerning patients’ adherence to treatment was obtained after downloading electronic 
cards from the ventilator, generating an objective and detailed measurement of the nightly 
usage of the devices. 
Adherence cutoff was established in more than 4hours/night of use and more than 70% of the 
nights. 
Statistical analysis 
Data was presented as mean value (standard deviation) and percentages. The Mann-Whitney 
U test and the Pearson Correlation Coefficient were used to deduce the correlations of the 
analyzed factors to treatment adherence. Wilcoxon test was used to compare paired variables. 
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Statistical significance was set at p<0.05. Statistical analysis was conducted using SPSS for 
Windows v19.0. 
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Results 
The mean age (SD) in our sample was 69 (10) years, 76% were males. Fourteen percent (7 
patients out of 50) had mixed pattern disease on lung function tests and 44% (19 patients out 
of 47) were on oxygenotherapy. The average adherence study period was 115 (84) days, 
ranging from 13 up to 366 days. Patients’ disease and ventilation characteristics are described 
in Table 1 and their treatment status in Figure 1. The results have shown that, in our sample, 
only 52% of OS patients are still on treatment. 
From January 2003 up to August 2011, the mean use time was 38 (29) months (46 patients 
out of 50), ranging from 4 up to 104 months.  
The mean usage time per night of the positive pressure ventilation system was 6:53 (2:37) 
hours (34 patients out of 50). Seventy four percent of patients (23 out of 31) used the 
ventilation machine for more than 70% of the nights. The mean daily use over 4hours was 
73% (30 patients out of 50). 
Patients with higher pre-titration PaCO2 were also the ones receiving oxygen (p=0.003). In 
this sample, patients on oxygenotherapy were not more adherent than patients without oxygen 
(p=0.058).  
There was no statistical difference in the treatment adherence between patients that had had a 
split-night polysomnography and the remaining patients (p=0.052). 
When we analyzed the deceased patients, we concluded that they were older (mean=75.7 
years, p=0.016) and had a lower FEV1 value (mean=1.06L, p=0.028). There were no 
differences in their adherence to treatment, blood gases, FEV1/FVC ratio and AHI when 
comparing them to the other patients. Regarding the individuals that were lost on follow-up, 
they had lower FEV1 (mean=0.93L, p=0.046) and higher PaCO2 (mean=53mmHg, p=0.008). 
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There was a negative correlation between PaCO2 and FEV1 (p=0.028). 
COPD exacerbation episodes and hospitalizations since January 2007 are displayed on Table 
2. There was no statistical difference between the exacerbations and hospitalizations pre and 
post treatment.  
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Discussion 
The objective of this study was to investigate the predictors of adherence to treatment with 
positive pressure systems in OS patients. To date, there is not any particular predictor factor 
consistently related to CPAP adherence(12). 
Preceding series including OS patients, like Marin and co-workers’(5), had younger patients, 
in average, higher FEV1 values and lower AHI, pointing milder disease severity, when 
compared to our analyzed population. 
Catcheside(10) states that, in OSAS, after 3 years, 12-25% of patients abandon the treatment. 
In disagreement to this report, we have observed that in our sample only 4% abandoned 
voluntarily the treatment. However, if we take into account patients that we have lost during 
follow-up, our abandonment percentage would be 18% in 38 months. 
We have no data regarding initial refusals to treatment, conversely it was previously stated 
that up to 50% of patients may refuse this treatment immediately(10). 
Previous series have shown that symptomatic disease, symptom relieve, severe but 
asymptomatic OSAS, higher pressures(10,12) and younger age(13) account for the adherence 
variation, however it was not possible to achieve the same conclusions in our study sample. 
Nevertheless, we found a positive correlation of pre-titration PaCO2 to the adherence to 
positive pressure ventilation system treatment. This correlation is probably related to COPD 
severity due to impaired gas exchange in the most severe diseased patients. There was a 
correlation with post-titration PaO2, but we could not attain any conclusion from this result, 
since this value represents an improvement during the titration and does not correspond to the 
whole treatment (though PaO2 is expected to improve with treatment). Previous data suggests, 
instead, a weak correlation of nocturnal hypoxemia with CPAP adherence(12).  
12 
 
A prior study by Mansfield and Naughton(14), including OS patients, observed that adherent 
patients had higher AHI. Correlation of PaCO2 to adherence was non-significant. In contrast 
to ours, this study included patients with hypoventilation-obesity syndrome, they had a 
smaller sample (14 individuals), the average compliance was 4:48hours, follow-up was 
shorter and patients were treated with CPAP. Hours meter system was used instead of 
electronic cards. 
In opposition to our study, others have found that 29-83% of patients with OSAS were non-
adherent(9,10,15), when considering 4hours/night as the cutoff point. O’Brien and co-
workers(16) have found an average nightly use of 3:51hours/night in OS patients. In their 
sample, patients were younger, they had higher FEV1 and lower AHI, suggesting lesser 
severity, which may be related to lower adherence. 
In all the compared series, patients were treated with CPAP, which may have contributed to 
differences in the adherence that we have found. 
The deceased patients were older and had lower FEV1 values, which suggests that those were 
the individuals with most severe COPD. Looking at the patients with lost follow-up, they had 
even smaller FEV1 and higher PaCO2. This raises an important question about what really has 
happened to them. Did they abandon treatment? Did they die? 
The negative correlation between PaCO2 and FEV1 might be explained by the disease 
severity: decreased FEV1 results from inflammation and narrowing of peripheral airways and 
airway collapse in more severe emphysema and parenchyma destruction by emphysema leads 
to impaired gas exchange(11). 
In our analysis, we could not find a benefit in COPD exacerbations after treatment initiation, 
contrary to Marin and co-workers(5). Reducing the number of COPD exacerbations is a 
manner of weighting the overall quality of treatment(17). Mansfield and Naughton(14) 
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reported a reduction in hospitalization rates in patients treated with CPAP. The analysis of our 
data in this regard is limited, given that this is a retrospective study and the registered 
exacerbations are those that were severe enough to need medical attention. These numbers 
may not correspond to the real number of exacerbations and patients may have gone to other 
health care institutions.  
Our study has many other limitations regarding the acquisition of data. Our sampling is 
reduced (50 patients). This could be a reason for the lack of significant results in the analysis 
of variables such as the subjective severity of the disease, which is a common predictor of 
adherence to treatment(9,10). We had no data on disease improvement, side effects and 
psychosocial factors in each patient, which has also limited our study(9,10). 
The advantage of our work over previous series is that we used data from ventilators’ 
electronic cards, which provided us with accurate estimate of overall and daily machine use. 
Previous studies assessed adherence using hours on a meter integrated in the machine, which 
may not grant objective information regarding ventilators’ use(18). 
It could be interesting to analyze the correlation of education before treatment initiation and 
close support for possible initial troubles with the adherence(9,10). However, our patients 
were not included on educational sessions. So far, we only include OSAS patients in 
educational sessions. 
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Conclusions 
We identified a positive correlation of adherence to treatment with positive pressure systems 
to pre-titration PaCO2 and post-titration PaO2. Overall, our patients’ adherence to treatment 
was better than expected from previous series, which could be related to the older age and 
superior disease severity in our sample. 
No differences were found between the COPD exacerbations and hospitalizations previous 
and after treatment initiation. 
Further studies are required to provide evidence on the most important predictors of 
adherence. 
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Tables and Figures 
 
Table 1 – Overlap Syndrome patients’ disease and ventilation characteristics. The 
significance of correlation with adherence to treatment was set at p<0.05. 
 n Mean SD p value 
Patients’ characteristics     
Age (years) 50 69 10 0.683 
Disease Features     
FEV1/FVC (%) 45 60 15 0.729 
FEV1 (L) 45 1.47 0.66 0.278 
AHI  21 39 18 0.225 
ESS 16 11 7 0.978 
BMI (kg/m2) 21 32 4 0.582 
Pre-titration Data     
Respiratory Rate (cpm) 47 22 5 0.226 
pH  33 7.41 0.04 0.466 
PaO2 (mmHg) 36 64 16 0.170 
PaCO2 (mmHg) 35 51 7 0.031* 
Post-titration Data     
PaO2 (mmHg) 15 72 19 0.037* 
PaCO2 (mmHg) 15 52 10 0.859 
 
 
 
 
 
 (continues) 
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AHI: Apnea-Hypopnea Index; BMI: Body Mass Index; CPAP: Continuous Positive Airway 
Pressure; EPAP: Expiratory Positive Airway Pressure; ESS: Epworth Sleepiness Scale; 
FEV1: Forced Expiratory Volume in 1 second; IPAP: Inspiratory Positive Airway Pressure 
 
 n Mean SD p value 
Ventilation data     
IPAP (cmH2O) 49 19 3 0.276 
EPAP (cmH2O) 49 10 2 0.901 
CPAP (cmH2O) 1 12 -     - 
Nasal Interface (%) 50 50 - 0.054 
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Figure 1 – Patients’ treatment with positive pressure ventilation system status (n=50). 
Treatment: patients continuing under treatment; Death: deceased patients; Lost of follow-up: 
patients without associated ventilator supplier company; Voluntary abandonment: patients 
that declared their will to stop treatment; Treatment suspension for medical decision: 
treatment arrest for low adherence. 
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Table 2 – COPD exacerbation episodes and hospitalizations before and after treatment with 
positive pressure ventilation system initiation (n=23). Significance was set at p<0.05. 
 
 
 Number of events 
 0 1 ≥2 p value 
Exacerbations     
Pre-treatment 17 2 4 
0.317 
Post-treatment 17 5 1 
Hospitalizations     
Pre-treatment 18 2 3 
0.589 
Post-treatment 18 4 1 
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